Sign in Sign up for free

Theratechnologies Revenue Y/Y

What is the Revenue Y/Y of Theratechnologies?

The Revenue Y/Y of Theratechnologies Inc. is 10.25%

What is the definition of Revenue Y/Y?

Yearly revenue growth is the percentage growth of the company’s revenue over trailing twelve months.

= (revenue past four quarters - revenue previous four quarters) / revenue previous four quarters

The yearly revenue growth rate is calculated as the percentage change in revenue over the trailing twelve months. For this specific metric, the calculation takes into account a series of the last eight quarterly revenues. The revenue growth is useful for determining the success of the company expanding its main business. Revenue growth of 5% to 10% is usually considered good for large-cap companies. For other companies, a sales growth of over 10% is more desirable.

Revenue Y/Y of companies in the Health Care sector on NASDAQ compared to Theratechnologies

What does Theratechnologies do?

theratechnologies inc., a biopharmaceutical company, markets prescription products in the united states, europe, and canada. it offers egrifta and egrifta sv, for the reduction of excess abdominal fat in human immunodeficiency virus (hiv)-infected patients with lipodystrophy; and trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant hiv-1 infected patients. the company's pipeline products include f8 formulation that could be used for the treatment of hiv-associated lipodystrophy; th-1902 for the treatment of triple negative breast cancer; and th-1904 for the treatment of ovarian cancer. the company was founded in 1993 and is headquartered in montreal, canada.

Companies with revenue y/y similar to Theratechnologies